Founder and M.D.
Founder, provider, and medical director at our medspa, Dr. Sherly Soleiman has dedicated her entire sub-specialty to the art and safety of minimally invasive procedures using and teaching the latest and most advanced techniques. She is one of the most requested local faculties for Allergan (the company that makes Botox, Juvederm, Voluma, and Kybella), teaching other doctors and nurses how to inject their products safely and accurately.
Dr. Sherly Soleiman is very passionate about the art of injectables. It all started about 9 years ago when a filler procedure under her eyes by a reputable injector resulted in an unfavorable outcome. Since that event, Dr. Soleiman took it upon herself to learn all there is to know about the dynamics, safety, and different techniques of injections.
Dr. Soleiman understands the artistic side of providing cosmetic injections to her patients. In her vast array of studies, she has taken sculpting classes, studied painters, make-up artists, and photoshop specialist. All of these things have allowed her to gain extended knowledge of facial features, differentiators of male and female facial contours, as well as how lights and shadows can affect the signs of aging. With her extensive studies, she was able to share her knowledge with other providers and improve the artistic approach that is offered by everyone in the medspa. As a result, a more youthful appearance can be achieved.
Over the many years of dedication to the non-invasive cosmetic world, Dr. Soleiman has advanced to faculty level, being on the Advisory Board and becoming a clinical researcher in multiple injectables studies for Allergan (the company that makes Botox, Voluma, Juvederm, and Kybella).
The Lumenis Stellar M22 is a multi-modality laser platform integrating Intense Pulsed Light (IPL), ResurFX (1565 nm non-ablative fractional laser), and Nd:YAG (long-pulsed and Q-switched 1064 nm) technologies. This system addresses over 30 indications, including skin...
The Cutera Excel V laser system combines 532 nm KTP and 1064 nm Nd:YAG wavelengths to address a wide range of vascular and pigmented skin concerns, including facial veins, rosacea, melasma, and lentigines, with clinical evidence supporting its safety and efficacy...
IV therapy and vitamin injections deliver nutrients directly into the bloodstream, bypassing the digestive system for rapid absorption. These treatments are used for specific medical indications such as nutrient deficiencies, malabsorption, and recovery from illness...
Acquired ptosis, or drooping of the upper eyelid, affects millions of adults and can impair both vision and appearance. Oxymetazoline 0.1% ophthalmic solution (Upneeq®) is the first FDA-approved, non-surgical therapy for acquired blepharoptosis in adults, offering...
Bimatoprost ophthalmic solution 0.03% (Latisse®) is the only FDA-approved prescription treatment for eyelash hypotrichosis, clinically proven to enhance eyelash length, thickness, and darkness through stimulation of the hair growth cycle. Since its approval in 2008...
Polidocanol, marketed as Asclera® in the United States, is an FDA-approved sclerosing agent used for the nonsurgical treatment of spider veins and reticular veins. Its efficacy and safety are supported by extensive clinical research, positioning it as a leading option...
GLP-1 and GIP agonist injectables, including semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™), have transformed evidence-based medical weight loss, achieving up to 20% body weight reduction in clinical trials. Rapid weight loss can lead to...
Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and exosomes represent the forefront of regenerative injectables, offering cell-based and cell-free options for tissue repair, wound healing, and aesthetic rejuvenation. These therapies leverage autologous or...
Exosomes and bioceramic fillers represent a significant advancement in regenerative and aesthetic medicine, offering new possibilities for tissue repair, skin rejuvenation, and facial contouring. Exosomes—cell-derived vesicles—deliver bioactive signals that support...
Sculptra® (poly-L-lactic acid) is an FDA-approved biostimulatory injectable designed to restore facial and body volume by stimulating the body’s natural collagen production. Backed by extensive clinical research, Sculptra® offers gradual, long-lasting improvement in...
Calcium hydroxylapatite (CaHA), marketed as Radiesse®, is a biostimulatory dermal filler recognized for its dual ability to restore facial volume and stimulate collagen production, resulting in both immediate and long-term improvements in facial aesthetics. At...
Hyaluronic acid (HA) dermal fillers are the leading nonsurgical solution for facial volume restoration, wrinkle correction, and soft tissue augmentation. With over 5.3 million HA filler procedures performed in the U.S. in 2023, these injectables remain the most widely...
Botulinum neurotoxins (BoNTs) are cornerstone agents in both cosmetic and therapeutic medicine, with decades of research supporting their efficacy and safety for wrinkle reduction, muscle spasticity, dystonia, and pain management. At Cosmetic Injectables Center...
Botox® (onabotulinumtoxinA) is widely recognized for its ability to smooth facial wrinkles, but its therapeutic applications extend far beyond aesthetics. As a neuromodulator, Botox is FDA-approved and clinically validated for a range of medical conditions involving...
PDO (polydioxanone) threads offer a minimally invasive medical aesthetic procedure designed to lift and tighten sagging skin while stimulating natural collagen production. This treatment provides a non-surgical alternative for facial and body rejuvenation, addressing...
